Lower Risk of Cancer in Patients on Metformin in Comparison With Those on Sulfonylurea Derivatives: Results from a large population-based follow-up study

OBJECTIVE: Numerous studies have suggested a decreased risk of cancer in patients with diabetes on metformin. Because different comparison groups were used, the effect magnitude is difficult to estimate. Therefore, the objective of this study was to further analyze whether, and to what extent, use o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ruiter, Rikje, Visser, Loes E., van Herk-Sukel, Myrthe P.P., Coebergh, Jan-Willem W., Haak, Harm R., Geelhoed-Duijvestijn, Petronella H., Straus, Sabine M.J.M., Herings, Ron M.C., Stricker, Bruno H.Ch.
Format: Artigo
Idioma:Inglês
Publicat: American Diabetes Association 2012
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3241334/
https://ncbi.nlm.nih.gov/pubmed/22100960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc11-0857
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars